Technetium-99m ethylene dicysteine: a new renal tubular function agent

Area of Science:

• Nuclear Medicine
• Radiopharmaceutical Chemistry
• Renal Physiology

Background:

• Technetium-99m ethylene dicysteine (99mTc-EC) is a novel renal tubular function tracer.
• It serves as an alternative to ortho-iodohippurate (OIH) and offers imaging comparable to 99mTc-mercaptoacetyltriglycine (MAG3).
• 99mTc-EC is eliminated primarily through active tubular transport.

Purpose of the Study:

• To evaluate 99mTc-EC as a renal imaging agent and tubular function index.
• To compare its characteristics with established tracers like OIH and 99mTc-MAG3.
• To assess its utility, particularly in patients with renal failure.

Main Methods:

• Evaluation of 99mTc-EC preparation, stability, and handling.
• Assessment of plasma clearance, renal extraction ratio, and distribution volume.
• Comparison of 99mTc-EC imaging qualities and biodistribution with OIH and 99mTc-MAG3.

Main Results:

• 99mTc-EC exhibits plasma clearance approximately 0.75 of OIH clearance, with a strict correlation.
• Renal extraction ratio is 0.70; distribution volume is larger than 99mTc-MAG3 and OIH.
• Lower liver uptake and high urinary excretion (70% within 1 hour) are observed, beneficial for renal failure patients.

Conclusions:

• 99mTc-EC is a suitable renal imaging agent providing an index of tubular function with high-quality images.
• Its ease of preparation, stability, and favorable biodistribution make it attractive, especially compared to OIH.
• Clinical adoption depends on cost and availability, but it shows promise for various renal applications.